BioCentury | Nov 17, 2014
Emerging Company Profile

Treating CRPC failures

...D. et al. "Galeterone, abiraterone, orteronel and ketoconazole exhibit differential inhibitory effects on CYP17 and steroidogenesis."...
BioCentury | Nov 4, 2013
Emerging Company Profile

Atterocor: Attacking ACC

...cholesterol. The goal was to cut off the source of cholesterol and thus block adrenal steroidogenesis...
BioCentury | Nov 20, 2000
Company News

Steroidogenesis management update

Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Transition: Janet Greeson to CEO from president; replacing Bert Wollen, who becomes president; Greeson also becomes president and Wollen becomes CEO of STGI's Samaritan...
BioCentury | Jun 26, 2000
Company News

Steroidogenesis management update

...Board, B7) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Promoted: Janet Greeson to president from...
BioCentury | Jun 26, 2000
Company News

Steroidogenesis board of directors update

...Management, B8) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Resigned: Alfred Sapse as chairman Appointed...
BioCentury | May 1, 2000
Clinical News

Anticort procaine infacaps: Phase Ib

...to Anticort treatment. The trial will assess immune response as well as quality of life. Steroidogenesis Inhibitors International Inc....
BioCentury | Feb 22, 2000
Company News

Steroidogenesis management update

...Financing, B16) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Departed: Alfred Sapse as president and...
BioCentury | Apr 19, 1999
Company News

Steroidogenesis Inhibitors International, Altachem-Pharma Ltd. deal

...final total of license fees that STGI has received to $300,000 (see BioCentury, April 12). Steroidogenesis...
BioCentury | Apr 12, 1999
Clinical News

Anticort procaine: Began Phase I testing

Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Product: Anticort procaine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: Altachem Pharma Ltd. (ASE:AAF, Edmonton, Alberta),...
BioCentury | Mar 15, 1999
Clinical News

Anticort procaine: Began Phase Ib testing

Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Product: Anticort procaine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: STGI began U.S. Phase Ib testing...
Items per page:
1 - 10 of 16
BioCentury | Nov 17, 2014
Emerging Company Profile

Treating CRPC failures

...D. et al. "Galeterone, abiraterone, orteronel and ketoconazole exhibit differential inhibitory effects on CYP17 and steroidogenesis."...
BioCentury | Nov 4, 2013
Emerging Company Profile

Atterocor: Attacking ACC

...cholesterol. The goal was to cut off the source of cholesterol and thus block adrenal steroidogenesis...
BioCentury | Nov 20, 2000
Company News

Steroidogenesis management update

Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Transition: Janet Greeson to CEO from president; replacing Bert Wollen, who becomes president; Greeson also becomes president and Wollen becomes CEO of STGI's Samaritan...
BioCentury | Jun 26, 2000
Company News

Steroidogenesis management update

...Board, B7) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Promoted: Janet Greeson to president from...
BioCentury | Jun 26, 2000
Company News

Steroidogenesis board of directors update

...Management, B8) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Resigned: Alfred Sapse as chairman Appointed...
BioCentury | May 1, 2000
Clinical News

Anticort procaine infacaps: Phase Ib

...to Anticort treatment. The trial will assess immune response as well as quality of life. Steroidogenesis Inhibitors International Inc....
BioCentury | Feb 22, 2000
Company News

Steroidogenesis management update

...Financing, B16) Steroidogenesis Inhibitors International Inc. (STGI), Las Vegas, Nev. Business: Infectious diseases Departed: Alfred Sapse as president and...
BioCentury | Apr 19, 1999
Company News

Steroidogenesis Inhibitors International, Altachem-Pharma Ltd. deal

...final total of license fees that STGI has received to $300,000 (see BioCentury, April 12). Steroidogenesis...
BioCentury | Apr 12, 1999
Clinical News

Anticort procaine: Began Phase I testing

Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Product: Anticort procaine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: Altachem Pharma Ltd. (ASE:AAF, Edmonton, Alberta),...
BioCentury | Mar 15, 1999
Clinical News

Anticort procaine: Began Phase Ib testing

Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Product: Anticort procaine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: STGI began U.S. Phase Ib testing...
Items per page:
1 - 10 of 16